The 2021 purchase of the respiratory pharmaceutical company Vectura by Phillip Morris International has been criticised by the public health and medical community, as a conflict of interest, with little input to date, from the patient community or the public.

Read the Publication: https://thorax.bmj.com/content/early/2022/07/14/thorax-2022-219142